Reaction
Pneumonia Adenoviral reporting signals
As of the last recalculation, Pneumonia Adenoviral appears in 189 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is MELPHALAN HYDROCHLORIDE (PRR 156.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Melphalan Hydrochloride | 30 | 156.4 | 156.6 |
| Melphalan | 27 | 152.3 | 152.5 |
| Alemtuzumab | 20 | 127.2 | 127.4 |
| Fludarabine Phosphate | 34 | 115.9 | 116.0 |
| Acetylcysteine | 8 | 97.6 | 97.7 |
| Busulfan | 12 | 89.6 | 89.7 |
| Sirolimus | 10 | 86.3 | 86.3 |
| Azacitidine For | 13 | 84.4 | 84.5 |
| Sorafenib | 14 | 80.1 | 80.1 |
| Thiotepa | 6 | 71.4 | 71.5 |
| Ifosfamide | 12 | 65.6 | 65.6 |
| Azacitidine | 13 | 51.7 | 51.8 |